Practice Areas - Equity Capital Markets Law Firms and Lawyers
Deal Date: | 05-02-2018 | Practice Area: | Equity Capital Markets |
Deal Title: | Seattle Genetics, Inc SEC-Registered Equity Offering | Industry: | Pharmaceuticals & Biotechnology |
Description: |
Davis Polk advised the joint book-running managers and representatives of the underwriters in connection with an SEC-registered offering by Seattle Genetics, Inc. of 13,269,230 shares of common stock, which included 1,730,769 shares of common stock sold pursuant to the exercise of the underwriters' over-allotment option.
|
||
Financial Center: | Silicon Valley | Value: | 0.00-100.00 |
Advised Party: | Underwriter | Law Firm | Davis Polk |
Issuer Jurisdiction - | United States | Listing Jurisdiction - | United States |
Classification: |
Secondary Offerings and Placings NASDAQ: |
Lawyer | Alan F Denenberg |